(Q47698901)

4 February 2018

title

Relation between gastric emptying of glucose and plasma concentrations of glucagon-like peptide-1. (English)

1 reference

4 February 2018

author

Karen L. Jones

4

1 reference

4 February 2018

author name string

Wishart JM

1

1 reference

4 February 2018

Horowitz M

2

1 reference

4 February 2018

Morris HA

3

1 reference

4 February 2018

Nauck MA

5

1 reference

4 February 2018

publication date

1 January 1998

1 reference

4 February 2018

published in

Peptides

1 reference

4 February 2018

volume

19

1 reference

4 February 2018

issue

6

1 reference

4 February 2018

page(s)

1049-1053

1 reference

4 February 2018

Human studies with glucagon-like-peptide-1: potential of the gut hormone for clinical use.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

The effect of short-term dietary supplementation with glucose on gastric emptying in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Glucagon-like peptide I reduces postprandial glycemic excursions in IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Pyloric motor response to intraduodenal dextrose involves muscarinic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Physiological role of cholecystokinin on postprandial insulin secretion and gastric meal emptying in man. Studies with the cholecystokinin receptor antagonist loxiglumide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

The effect of short-term dietary supplementation with glucose on gastric emptying of glucose and fructose and oral glucose tolerance in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Disordered gastric motor function in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Effect of meal volume and energy density on the gastric emptying of carbohydrates

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Altered postprandial insulin requirement in IDDM patients with gastroparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Reduced postprandial blood glucose levels in recently diagnosed non-insulin-dependent diabetics secondary to pharmacologically induced delayed gastric emptying

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Gastric emptying and release of incretin hormones after glucose ingestion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Gastric emptying in Mexican Americans compared to non-Hispanic whites.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

A role for glucagon-like peptide-1 in the central regulation of feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2898%2900052-7

7 January 2021

10.1016/S0196-9781(98)00052-7

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018